Skip to main content

Table 3 Univariate associations (odds ratio and their 95% CI) between GPs (n = 399) characteristics and adherence to Indonesian type 2 Diabetes Mellitus (T2DM) guideline recommendations

From: Awareness, agreement, adoption and adherence to type 2 diabetes mellitus guidelines: a survey of Indonesian primary care physicians

 

Diagnosis

Lifestyle modification

Sulfonylurea for treatment

Blood glucose target

Blood pressure target

Statin prescription

Adherent participants: n (%)

67 (45)

145 (36)

111 (37)

61 (21)

113 (28)

118 (34)

Characteristics

      

Years of practice

      

  16 – 45*

      

  0 – 15

1.2 (0.8-1.7)b

1.4 (0.9-2.2)c

0.8 (0.6-1.3)b

0.8 (0.5-1.3)c

1.0 (0.7-1.6)c

0.7 (0.5-1.1)c

Gender

      

  Female*

      

  Male

1.1 (0.7-1.7)a

0.7 (0.5-1.2)b

1.3 (0.8-2.0)a

0.8 (0.5-1.4)b

0.8 (0.5-1.3)b

1.0 (0.6-1.6)b

Practice type

      

  Non solo practice*

      

  Solo practice

0.8 (0.6-1.2)a

0.7 (0.5-1.1)c

0.9 (0.6-1.3)b

1.0 (0.6-1.7)c

1.2 (0.8-1.9)c

1.0 (0.6-1.4)b

Practice location

      

  Outside Jakarta*

      

  Jakarta

0.9 (0.6-1.4)c

1.5 (1.0-2.3)d

1.0 (0.6-1.6)c

0.8 (0.5-1.4)d

1.1 (0.7-1.7)d

1.1 (0.7-1.7)d

DM training

      

  No*

      

  Yes

1.1 (0.7-1.7)b

1.3 (0.8-2.0)d

1.2 (0.8-1.9)c

1.0 (0.6-1.7)d

1.0 (0.6-1.6)d

1.1 (0.7-1.7)d

Proportion DM patients

      

  10% and above*

      

  <10%

1.0 (0.7-1.5)b

0.8 (0.5-1.2)c

0.9 (0.6-1.4)b

1.5 (0.9-2.5)c

1.1 (0.7-1.8)c

0.7 (0.5-1.1)c

  1. Missing data: a:0- < 5%, b:5-10%, c:>10-15%, d:>15-19%.
  2. *reference.
  3. Adherence to screening was not included in the univariate analysis since the number of events were too small (seven events).
  4. • Life-style modification: years of practice, practice type, practice location.
  5. Associations which have p value <0.2,
  6. • Life-style modification: years of practice, practice type, practice location.
  7. • Blood glucose target: proportion of diabetes patients.
  8. • Statin: years of practice, proportion of diabetes patients.
  9. • Diagnosis, sulfonylurea for treatment and blood pressure target: none.